Lovastatin improves endothelial cell function in LMNA-related DCM
Nature Reviews Cardiology, Published online: 11 August 2020; doi:10.1038/s41569-020-0432-6A new clinical trial in a dish study sheds light on a new mechanism that restores endothelial dysfunction with lovastatin in induced pluripotent stem cells that are derived from patients with dilated cardiomyopathy.
Source: Nature Reviews Cardiology - Category: Cardiology Authors: Andrew Robson Source Type: research
More News: Cardiology | Cardiomyopathy | Clinical Trials | Dilated Cardiomyopathy | Heart | Lovastatin | Stem Cell Therapy | Stem Cells | Study